Laura Barrow

413 total citations
13 papers, 324 citations indexed

About

Laura Barrow is a scholar working on Gastroenterology, Surgery and Pharmacy. According to data from OpenAlex, Laura Barrow has authored 13 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Gastroenterology, 6 papers in Surgery and 2 papers in Pharmacy. Recurrent topics in Laura Barrow's work include Gastrointestinal motility and disorders (11 papers), Intestinal Malrotation and Obstruction Disorders (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Laura Barrow is often cited by papers focused on Gastrointestinal motility and disorders (11 papers), Intestinal Malrotation and Obstruction Disorders (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Laura Barrow collaborates with scholars based in United States. Laura Barrow's co-authors include Kunwar Shailubhai, Patrick Griffin, William Koltun, Philip B. Miner, Gary S. Jacob, John A. Foss, Gail M. Comer, Leslie Magnus, Gregory Wiener and Michael DeMicco and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Digestive Diseases and Sciences.

In The Last Decade

Laura Barrow

13 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Barrow United States 7 258 215 39 30 28 13 324
Nicolas A. Pardon Spain 4 295 1.1× 242 1.1× 47 1.2× 62 2.1× 36 1.3× 9 358
Meritxell Guilà Spain 4 233 0.9× 123 0.6× 82 2.1× 103 3.4× 30 1.1× 5 332
Anne‐Mette Haase Denmark 11 224 0.9× 125 0.6× 86 2.2× 44 1.5× 11 0.4× 18 362
Guido Iantorno Argentina 7 199 0.8× 168 0.8× 32 0.8× 11 0.4× 10 0.4× 11 284
Iordanis Karagiannidis United States 6 113 0.4× 55 0.3× 22 0.6× 24 0.8× 11 0.4× 16 197
Stéphanie Mondelaers Belgium 5 135 0.5× 55 0.3× 51 1.3× 21 0.7× 30 1.1× 9 181
Andrea Materna Denmark 8 175 0.7× 68 0.3× 116 3.0× 33 1.1× 37 1.3× 12 295
Suma Magge United States 6 310 1.2× 154 0.7× 37 0.9× 77 2.6× 7 0.3× 10 429
Sun‐Chuan Dai United States 5 207 0.8× 157 0.7× 63 1.6× 68 2.3× 18 0.6× 10 309
E. Miceli Italy 8 92 0.4× 69 0.3× 51 1.3× 16 0.5× 17 0.6× 18 163

Countries citing papers authored by Laura Barrow

Since Specialization
Citations

This map shows the geographic impact of Laura Barrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Barrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Barrow more than expected).

Fields of papers citing papers by Laura Barrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Barrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Barrow. The network helps show where Laura Barrow may publish in the future.

Co-authorship network of co-authors of Laura Barrow

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Barrow. A scholar is included among the top collaborators of Laura Barrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Barrow. Laura Barrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Miner, Philip B., William Koltun, Gregory Wiener, et al.. (2017). A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation. The American Journal of Gastroenterology. 112(4). 613–621. 99 indexed citations
2.
DeMicco, Michael, et al.. (2017). Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation. Therapeutic Advances in Gastroenterology. 10(11). 837–851. 52 indexed citations
3.
Miner, Philip B., et al.. (2016). Sa1440 A Phase III Study of the Efficacy and Safety of Plecanatide in the Treatment of Chronic Idiopathic Constipation (CIC) (Study-00). Gastroenterology. 150(4). S316–S316. 1 indexed citations
4.
Krause, Richard A., et al.. (2016). Sa1444 Effect of Plecanatide on Stool Consistency in the Treatment of Chronic Idiopathic Constipation (CIC): Results from Two Phase III Studies. Gastroenterology. 150(4). S317–S318. 3 indexed citations
5.
Barrow, Laura, et al.. (2016). Safety and Tolerability of Plecanatide in Patients with Chronic Idiopathic Constipation: Long-term Evidence from an Open-Label Study. The American Journal of Gastroenterology. 111. S248–S249. 1 indexed citations
6.
Morgan, William, et al.. (2016). Sa1443 Effect of Plecanatide on Patient Assessments in Chronic Idiopathic Constipation (CIC): Results From Two Phase III Studies. Gastroenterology. 150(4). S317–S317. 3 indexed citations
7.
8.
Barrow, Laura, et al.. (2016). Efficacy and Safety of Plecanatide in the Treatment of Chronic Idiopathic Constipation (CIC): Pooled Results from Two Phase 3 Studies: 2016 ACG Presidential Poster Award. The American Journal of Gastroenterology. 111. S237–S237. 1 indexed citations
9.
Miner, Philip B., Robert DeLuca, William Koltun, et al.. (2014). Plecanatide, a Novel Uroguanylin Analog: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate Efficacy and Safety in Patients With Irritable Bowel Syndrome With Constipation (IBS-C). The American Journal of Gastroenterology. 109. S541–S541. 29 indexed citations
10.
Shailubhai, Kunwar, et al.. (2013). Plecanatide, an Oral Guanylate Cyclase C Agonist Acting Locally in the Gastrointestinal Tract, Is Safe and Well-Tolerated in Single Doses. Digestive Diseases and Sciences. 58(9). 2580–2586. 79 indexed citations
11.
12.
Shailubhai, Kunwar, et al.. (2011). Plecanatide, a Guanylate Cyclase C Agonist, Improves Bowel Habits and Symptoms Associated with Chronic Constipation in a Phase IIa Clinical Study. The American Journal of Gastroenterology. 106. S502–S502. 14 indexed citations
13.
Barrow, Laura, et al.. (1993). A Comparison of Isokinetic Eccentric Exercise on Delayed-Onset Muscle Soreness and Creatine Kinase in the Quadriceps Versus the Hamstrings. Isokinetics and Exercise Science. 3(2). 68–73. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas A. Pardon Breakdown of academic impact, for papers by Meritxell Guilà Breakdown of academic impact, for papers by Anne‐Mette Haase Breakdown of academic impact, for papers by Guido Iantorno Breakdown of academic impact, for papers by Iordanis Karagiannidis Breakdown of academic impact, for papers by Stéphanie Mondelaers Breakdown of academic impact, for papers by Andrea Materna Breakdown of academic impact, for papers by Suma Magge Breakdown of academic impact, for papers by Sun‐Chuan Dai Breakdown of academic impact, for papers by E. Miceli
Rankless by CCL
2026